HC Wainwright Weighs in on Foghorn Therapeutics Inc.’s Q3 2024 Earnings (NASDAQ:FHTX)

Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) – Investment analysts at HC Wainwright cut their Q3 2024 EPS estimates for shares of Foghorn Therapeutics in a research report issued on Tuesday, May 7th. HC Wainwright analyst A. Fein now anticipates that the company will earn ($0.66) per share for the quarter, down from their prior […]

Leave a Reply

Your email address will not be published.

Previous post OneConnect Financial Technology (NYSE:OCFT) Trading Down 2.9%
Next post Brokers Set Expectations for TransAlta Co.’s Q3 2024 Earnings (NYSE:TAC)